Original Article
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness

https://doi.org/10.1016/j.jaip.2020.12.045Get rights and content

Background

There is a paucity of information on coronavirus disease 2019 (COVID-19) outcomes in asthmatics.

Objective

To identify risk factors associated with admission and subsequent mortality among COVID-19–infected asthmatics.

Methods

Adults at our institution with a positive polymerase chain reaction for COVID-19 between March 14 and April 27, 2020, were retrospectively identified. Comorbidities, laboratory results, and mortality rates during hospitalization were recorded.

Results

In total, 737 of 951 (77.5%) asthma patients with COVID-19 were seen in the emergency department (ED), and 78.8% of these ED patients (581 of 737) were admitted. Individuals with previously measured mean absolute eosinophil counts (AEC) ≥150 cells/μL were less likely to be admitted (odds ratio [OR] = 0.46, 95% confidence interval [CI]: 0.21-0.98, P = .04), whereas concomitant heart failure (CHF), chronic kidney disease (CKD), and chronic obstructive pulmonary disease (COPD) were risk factors for admission. Hospitalized patients with asthma with peak hospital-measured AEC ≥150 cells/μL (n = 104) were less likely to die compared with those whose AEC remained <150 cells/μL (n = 213) (mortality rate 9.6% vs 25.8%; OR = 0.006, 95% CI: 0.0001-0.64, P = .03). This group had also higher preadmission mean AEC (237 ± 181 vs 163 ± 147 cells/μL, P = .001, OR = 2012, 95% CI: 27.3-14,816). The mortality rate in patients with asthma alone (no associated CHF, CKD, COPD, diabetes, or hypertension) was similar to that of patients without asthma or any of these comorbidities.

Conclusions

In asthmatics, pre-existing eosinophilia (AEC ≥150 cells/μL) was protective from COVID-19–associated admission, and development of eosinophilia (AEC ≥150 cells/μL) during hospitalization was associated with decreased mortality. Preadmission AEC influenced the AEC trend during hospitalization. Having a Th2-asthma phenotype might be an important predictor for reduced COVID-19 morbidity and mortality that should be further explored in prospective and mechanistic studies.

Key words

COVID-19
Asthma
Eosinophilia
Mortality

Abbreviations used

ACE2
Angiotensin-converting enzyme 2
AEC
Absolute eosinophil count
CHF
Congestive heart failure
CI
Confidence interval
CKD
Chronic kidney disease
CLG
Clinical Looking Glass
COPD
Chronic obstructive pulmonary disease
COVID-19
Coronavirus disease 2019
CRP
C-reactive protein
DM
Diabetes
ED
Emergency department
FEV1
Forced expiratory volume in 1 second
HTN
Hypertension
ICD
International Classification of Diseases
ICS
Inhaled corticosteroid
OR
Odds ratio
SARS-CoV-2
Severe acute respiratory syndrome coronavirus-2
TMPRSS2
Transmembrane protease serine 2

Cited by (0)

No funding was received for this work.

Conflicts of interest: The authors declare that they have no relevant conflicts of interest.

View Abstract